Lexicon Pharmaceuticals (LXRX) Posts Q4 Loss of 3c/Share

February 28, 2014 7:02 AM

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.03), $0.03 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found